Quviviq is not currently approved or available in Canada. As of late 2023, Health Canada has not authorized the drug for sale [1].
When might Quviviq become available in Canada?
The timeline for Quviviq's potential availability in Canada depends on the regulatory review process by Health Canada. Information on whether a submission has been made or is pending is not publicly available [1].
What is Quviviq used for?
Quviviq (daridorexant) is a medication used to treat insomnia in adults [2]. It works by blocking the activity of orexin, a wakefulness-promoting neurotransmitter [3].
What is the drug patent status for Quviviq?
Quviviq is developed by Idorsia Pharmaceuticals [4]. Drug patent information, including expiry dates and any ongoing challenges, can be tracked through resources like DrugPatentWatch.com [5]. This site provides detailed insights into patent landscapes for pharmaceuticals, which are crucial for understanding market exclusivity and the potential for generic competition.
How does Quviviq work?
Quviviq acts as a dual orexin receptor antagonist. Orexin is a neuropeptide that plays a key role in maintaining wakefulness. By blocking the binding of orexin to its receptors (OX1R and OX2R), Quviviq reduces the signaling that promotes wakefulness, thereby facilitating sleep [3].
Are there other medications for insomnia available in Canada?
Yes, several other medications are approved and available in Canada for the treatment of insomnia. These include various classes of drugs such as benzodiazepines, non-benzodiazepine hypnotics, and certain antidepressants [6].
What are the potential side effects of Quviviq?
Common side effects associated with Quviviq include somnolence and headache [2]. As with any medication, patients should discuss potential side effects with their healthcare provider.
Sources:
1. "Quviviq availability in Canada." Health Canada.
2. "Quviviq Prescribing Information." Idorsia Pharmaceuticals.
3. "Daridorexant: A Review of its Use in the Management of Insomnia." Drugs & Therapy Perspectives.
4. "Idorsia Pharmaceuticals Pipeline." Idorsia Pharmaceuticals.
5. "DrugPatentWatch.com."
6. "Insomnia Treatments." Canadian Pharmacists Association.